Dr Reddy's launches generic epilepsy drug in US
New Delhi: Dr Reddy's Laboratories said it has launched Levetiracetram in Sodium Chloride injection, an anti-epileptic drug, in the US market.
The Hyderabad-based company's drug is the generic version of HQ Specialty Pharma Corporation's product, Dr Reddy's Laboratories said in a statement.
According to IMS Health data, Levetiracetam in Sodium Chloride injection brand and generics had sales of around USD 37 million in the US market.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd